Chemotherapy before surgery for advanced pseudomyxoma peritonei
Treatments studied
Part of Cancer clinical trials.
This trial tests a chemotherapy combination (capecitabine and cyclophosphamide) given before surgery for people with a large amount of pseudomyxoma peritonei (PMP). The goal is to see if it can shrink the tumor and make surgery more effective.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be diagnosed with pseudomyxoma peritonei (a rare, slow-growing tumor in the abdomen).
- Your tumor must be large, as determined by a CT scan (PCI score greater than 28).
- You must be between 18 and 75 years old.
- You should be in fairly good health and able to care for yourself (ECOG score less than 2).
- Your liver, kidney, and blood cell counts must be within acceptable ranges.
- You cannot have had chemotherapy or other cancer treatments before, and you must not have certain conditions that affect how the body absorbs medication.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares a lower dose of heated chemotherapy (HIPEC) given during surgery to a standard dose for patients with pseudomyxoma peritonei (a condition where jelly-like mucus builds up in the abdomen). The goal is to see if the lower dose works just as well with fewer side effects.
This trial tests a vaccine for people with a rare abdominal cancer called pseudomyxoma peritonei (PMP) that has come back or cannot be removed by surgery. The vaccine is designed to help the immune system fight the cancer. It is for people whose tumor has a specific genetic change (GNAS mutation) and who have no other standard treatment options.
This trial compares two different schedules of heated chemotherapy (HIPEC) after surgery for pseudomyxoma peritonei (a rare appendix cancer that spreads in the abdomen). It may help determine whether one or three cycles of HIPEC is better for controlling the disease.
This trial tests whether the drug metformin (a common diabetes pill) can help control pseudomyxoma peritonei, a rare abdominal cancer. It is for people whose cancer has come back or cannot be surgically removed, and who aren't planning a major surgery with heated chemotherapy at this time.
This trial tests if an intestinal or multi-organ transplant can help people with a rare, widespread abdominal cancer called pseudomyxoma peritonei that cannot be removed by standard surgery. The goal is to remove all visible cancer and replace affected organs with a donated transplant.
This trial studies whether adding two chemotherapy medicines (capecitabine and temozolomide) to standard pre-surgery chemo-radiation can work better for people with locally advanced rectal cancer that has a specific tumor marker pattern (MGMT “silenced”) and is mismatch-repair proficient (MSS). It aims to shrink the tumor before surgery and improve cancer control.
Hear when a new Pseudomyxoma Peritonei trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.